KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.91 $2.61 Thursday, 25th Apr 2024 CHRS stock ended at $1.93. This is 4.46% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 6.28% from a day low at $1.91 to a day high of $2.03.
90 days $1.91 $2.87
52 weeks $1.44 $8.22

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Sep 20, 2023 $4.56 $4.73 $4.51 $4.51 1 720 898
Sep 19, 2023 $4.53 $4.62 $4.38 $4.61 2 353 285
Sep 18, 2023 $4.86 $4.87 $4.37 $4.53 4 026 677
Sep 15, 2023 $4.79 $4.97 $4.71 $4.92 16 669 156
Sep 14, 2023 $4.71 $4.88 $4.61 $4.78 2 103 291
Sep 13, 2023 $4.96 $5.02 $4.60 $4.68 3 457 368
Sep 12, 2023 $5.01 $5.18 $5.00 $5.04 4 178 032
Sep 11, 2023 $4.98 $5.22 $4.96 $5.05 3 131 334
Sep 08, 2023 $4.95 $5.07 $4.76 $4.89 2 490 816
Sep 07, 2023 $4.88 $4.94 $4.70 $4.89 2 045 799
Sep 06, 2023 $4.87 $5.07 $4.77 $4.98 2 398 238
Sep 05, 2023 $5.31 $5.33 $4.71 $4.89 7 233 742
Sep 01, 2023 $5.36 $5.47 $5.21 $5.45 2 207 999
Aug 31, 2023 $5.24 $5.40 $5.22 $5.33 1 501 896
Aug 30, 2023 $5.25 $5.35 $5.18 $5.24 1 137 032
Aug 29, 2023 $5.05 $5.28 $5.03 $5.27 1 993 347
Aug 28, 2023 $4.72 $5.07 $4.71 $5.05 1 714 910
Aug 25, 2023 $4.57 $4.73 $4.51 $4.70 1 123 730
Aug 24, 2023 $4.63 $4.63 $4.49 $4.57 932 387
Aug 23, 2023 $4.72 $4.97 $4.63 $4.64 2 053 109
Aug 22, 2023 $4.60 $4.67 $4.43 $4.64 1 137 494
Aug 21, 2023 $4.47 $4.64 $4.36 $4.60 1 790 218
Aug 18, 2023 $4.26 $4.52 $4.22 $4.47 1 463 533
Aug 17, 2023 $4.57 $4.58 $4.34 $4.35 1 608 576
Aug 16, 2023 $4.47 $4.59 $4.43 $4.53 1 413 841
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT